Declining trend in the indexed quarterly value growth
We see a declining trend in the indexed quarterly value growth of secondary sector medicines. Understanding the development of the secondary sector is a puzzle of trends and therapy area specific developments, some of which related to changes in the patent situation, volume changes in the use of specific medicines and new RADS guidelines affecting the use and uptake of new medicines.
DLI Market Intelligence monitor the market development across sectors and keep on top of structural changes within Danish healthcare. Details on the market development and insights supporting your business are only a call away.
Please contact us for more insights on the market development and the opportunities they may provide for the growth of your business.